DaVita Inc
davita.comDaVita Inc (NYSE: DVA) is a kidney care company that operates dialysis centers and provides kidney disease treatment services to patients across multiple care settings. Revenue comes primarily from providing dialysis treatments, billed to government payers such as Medicare and Medicaid and to commercial insurers on a per-treatment basis. DaVita describes itself as a comprehensive kidney care provider with more than 25 years of operating history, serving patients from early-stage chronic kidney disease through end-stage renal disease requiring dialysis, home treatment, hospital care, skilled nursing facilities, and transplant support. The company's patient base is defined by chronic kidney disease stages one through five, with stage five patients representing the core dialysis population. DaVita's scale in outpatient dialysis positions it alongside Fresenius Medical Care as one of the two dominant U.S. dialysis operators, though specific competitor revenue figures are not cited in the excerpts reviewed.
Products & Services
Outpatient hemodialysis, home dialysis support, in-hospital dialysis, skilled nursing facility dialysis, chronic kidney disease management services, and transplant support services.
Revenue Model
Per-treatment fee revenue billed to Medicare, Medicaid, and commercial health insurers for dialysis and kidney care services delivered across outpatient dialysis centers, home settings, hospitals, and skilled nursing facilities.
Customers & Markets
Patients with chronic kidney disease across all five disease stages, with end-stage renal disease patients as the primary dialysis customer. Payers include Medicare, Medicaid, and commercial health insurers.
Geographic Exposure
The filing excerpts reference global patient care but do not provide a specific country-by-country revenue breakdown. U.S. operations are the primary described business.
Loading...
